Review of Current Insights and Therapeutic Approaches for the Treatment of Refractory Postpartum Hemorrhage
Lilly Y Liu,Lisa Nathan,Jean-Ju Sheen,Dena Goffman
DOI: https://doi.org/10.2147/IJWH.S366675
2023-06-02
Abstract:Lilly Y Liu, Lisa Nathan, Jean-Ju Sheen, Dena Goffman Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA Correspondence: Lilly Y Liu, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, 622 West 168th Street, New York, NY, 10032, USA, Tel +1 919-389-2193, Email Refractory postpartum hemorrhage (PPH) affects 10– 20% of patients with PPH when they do not respond adequately to first-line treatments. These patients require second-line interventions, including three or more uterotonics, additional medications, transfusions, non-surgical treatments, and/or surgical intervention. Multiple studies have suggested that patients with refractory PPH have different clinical characteristics and causes of PPH when compared to patients who respond to first-line agents. This review highlights current insights into therapeutic approaches for the management of refractory PPH. Early management of refractory PPH relies on both hypovolemic resuscitation and achievement of hemostasis, with an emphasis on early blood product replacement and massive transfusion protocols. Transfusion needs can be more rapidly and accurately identified through point-of-care tests such as thromboelastography. Medical therapies for the treatment of refractory PPH involve treatment of both uterine atony as well as the underlying coagulopathy, with the use of tranexamic acid and adjunct therapies such as factor replacement. The principles guiding the management of refractory PPH include restoring normal uterine and pelvic anatomy, through the evaluation and management of retained products of conception, uterine inversion, and obstetric lacerations. Intrauterine vacuum-induced hemorrhage control devices are novel methods for the treatment of refractory PPH secondary to uterine atony, in addition to other uterine-sparing surgical procedures that are under investigation. Resuscitative endovascular balloon occlusion of the aorta can be considered for cases of critical refractory PPH, to prevent or decrease ongoing blood loss while definitive surgical interventions are performed. Finally, for patients with critical hemorrhage resulting in hemorrhagic shock, damage control resuscitation (a staged surgical approach focused on restoring normal physiologic recovery and maximizing tissue oxygenation prior to proceeding with definitive surgical management) has been shown to successfully control refractory PPH, with an overall mortality decrease for obstetric patients. Keywords: refractory postpartum hemorrhage, maternal mortality, critical care obstetrics Obstetric hemorrhage remains the leading cause of maternal mortality worldwide, accounting for 27% of maternal deaths. 1 Occurring after 5% of all live births, 2 PPH is a leading cause of severe maternal morbidity, resulting in significant short-term and long-term consequences to maternal health. 3 These consequences include the acute effects of hemorrhagic shock, such as multiorgan failure, transfusion-related morbidity, worsening of chronic anemia, and intensive care unit admission. 4 Furthermore, rates of PPH have continued to rise globally over the last decade. 5–7 Between 2010 and 2014 PPH rates increased by 13% in the United States, with uterine atony accounting for 79% of cases. 8 In addition to the numerous patient characteristics that independently increase the risk for PPH, studies have examined mode of birth and induction of labor as potential causes for the significant increase in rates of PPH; however, changes in known risk factors over this time period have yet to fully account for this trend. 9 Despite a global rise in the incidence of PPH, maternal mortality from obstetric hemorrhage continues to disproportionately affect patients of lower socioeconomic status and from low-resource countries, suggesting that a vast majority of these cases would be preventable with improved resources. 1,4 With early diagnosis, appropriate resources, and skilled providers and care teams, management of refractory PPH can be optimized to prevent severe maternal morbidity and mortality. 4 Postpartum hemorrhage is defined as a cumulative blood loss of 1000mL or greater, or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours of birth, regardless of the mode of birth. This definition was introduced by the American College of Obstetricians and Gynecologists' reVITALize program in 2014 in order to standardize obstetric definitions for PPH. 10 The majority of patients respond appropriately to first-line treatments for PPH, which include uterotonics, uterine massage, and tranexamic acid. However, 10–20% of these patients ultimately do not res -Abstract Truncated-
obstetrics & gynecology